Outlook Therapeutics Inc. buy BiotechBee
Start price
12.06.24
/
50%
€7.30
Target price
28.02.26
€10.00
Performance (%)
-80.96%
End price
14.12.24
€1.39
Summary
This prediction ended on 14.12.24 with a price of €1.39. The BUY prediction by BiotechBee for Outlook Therapeutics Inc. performed very badly with a performance of -80.96%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Outlook Therapeutics Inc. | 9.782% | 9.782% | -81.310% |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
According to BiotechBee what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Outlook Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0